关注
Du-San Baek
Du-San Baek
Galapagos Inc.
在 glpg.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-driven Src-Akt bypass signaling
YJ Kim, K Jung, DS Baek, SS Hong, YS Kim
Oncogene 36 (18), 2543-2552, 2017
552017
Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
WY Seo, JH Kim, DS Baek, SJ Kim, S Kang, WS Yang, JA Song, MS Lee, ...
Scientific reports 7 (1), 15946, 2017
472017
Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
YJ Kim, DS Baek, S Lee, D Park, HN Kang, BC Cho, YS Kim
Cancer letters 466, 23-34, 2019
312019
Construction of a large synthetic human Fab antibody library on yeast cell surface by optimized yeast mating
DS Baek, YS Kim
Journal of microbiology and biotechnology 24 (3), 408-420, 2014
312014
Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif
DS Baek, YS Kim
Biochemical and biophysical research communications 463 (3), 414-420, 2015
262015
FGFR4-targeted Chimeric antigen receptors combined with anti-myeloid polypharmacy effectively treat orthotopic Rhabdomyosarcoma
PM Sullivan, R Kumar, W Li, V Hoglund, L Wang, Y Zhang, M Shi, D Beak, ...
Molecular cancer therapeutics 21 (10), 1608-1621, 2022
202022
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo
DS Baek, YJ Kim, S Vergara, A Conard, C Adams, G Calero, R Ishima, ...
Cancer letters 525, 97-107, 2022
192022
Human antibody domains and fragments targeting neutrophil elastase as candidate therapeutics for cancer and inflammation-related diseases
X Chu, Z Sun, DS Baek, W Li, JW Mellors, SD Shapiro, DS Dimitrov
International Journal of Molecular Sciences 22 (20), 11136, 2021
152021
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
YJ Kim, W Li, DV Zhelev, JW Mellors, DS Dimitrov, DS Baek
Frontiers in Oncology 13, 1124039, 2023
112023
Human antibodies targeting ENPP1 as candidate therapeutics for cancers
X Chu, DS Baek, W Li, T Shyp, B Mooney, MG Hines, GB Morin, ...
Frontiers in Immunology 14, 1070492, 2023
102023
Immunoglobulin Fc-fused peptide without C-terminal Arg or Lys residue augments neuropilin-1-dependent tumor vascular permeability
DS Baek, JH Kim, YJ Kim, YS Kim
Molecular pharmaceutics 15 (2), 394-402, 2018
102018
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
N Saha, DS Baek, RP Mendoza, D Robev, Y Xu, Y Goldgur, ...
Biomedicine & Pharmacotherapy 161, 114494, 2023
72023
Yeast Mating as a Tool for Highly Effective Discovery and Engineering of Antibodies via Display Methodologies
DS Baek, SW Park, C Adams, DS Dimitrov, YS Kim
Yeast Surface Display, 313-333, 2022
12022
Anti-adam10 antibodies and uses in treatment of cancer
DSB Dimitar B. NIKOLOV, Dimiter Stanchev Dimitrov, Nayanendu Saha
2024
Molecules that bind to enpp1 polypeptides
2023
Molecules that bind to cd276 polypeptides
DB Dimiter Stanchev Dimitrov, Xianglei Liu, Wei Li, John W. Mellors
2023
Molecules that bind to neutrophil elastase polypeptides
DB Dimiter Stanchev Dimitrov, Xiaojie CHU, Steven David SHAPIRO, John W ...
WO Patent WO2023133338A2, 2023
2023
Discovery and pre-clinical evaluation of antibodies to the NKG2A inhibitory receptor
DS Baek, YJ Kim, W Li, BJC Macatangay, JC Cyktor, MG Hines, ...
bioRxiv, 2022.05. 18.492494, 2022
2022
MOLECULES THAT BIND TO CD66e POLYPEPTIDES
DB Dimiter Stanchev Dimitrov, John W. Mellors
WO Patent WO2022192281A1, 2022
2022
Molecules that bind to cd94/nkg2a heterodimer polypeptides
JWM Dimiter Stanchev Dimitrov, Dusan Baek, Yae Jin KIM
WO Patent WO2023114176A2, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20